New MRI technique for tiny lungs withdrawn before it began

NCT ID NCT04035629

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to test a special MRI technique using hyperpolarized xenon gas to get detailed images of lung function in infants with bronchopulmonary dysplasia (BPD). The goal was to see if this method could reveal areas of poor ventilation or gas exchange without using radiation. However, the study was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MagniXene (hyperpolarized xenon-129 gas)

What this could lead to

If successful, this imaging method could help doctors see how well different parts of the lung are working in infants with BPD, without using radiation.

What could go wrong

The study was withdrawn before any participants were enrolled, so no data was collected. The technique is still experimental and not yet proven in this population.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States